blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3294724

EP3294724 - IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE WITH REDUCED PARTICLE SIZE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.10.2019
Database last updated on 29.07.2024
FormerRequest for examination was made
Status updated on  16.02.2018
FormerThe international publication has been made
Status updated on  18.11.2016
Most recent event   Tooltip18.10.2019Application deemed to be withdrawnpublished on 20.11.2019  [2019/47]
Applicant(s)For all designated states
Davuluri, Ramamohan Rao
Sanali Info Park 'A' Block
Ground Floor 8-2-120/113 Rd. No 2
Banjara Hills
Hyderabad 500 034 / IN
[2018/12]
Inventor(s)01 / PONNAIAH, Ravi
3/414 Immanuel street
Tilak Nagar IyerBunglow
Madurai Tamil Nadu 625014 / IN
02 / NEEL PRAVEEN, Kumar
Flat No. 102 Balaji Enclave
Balaji Park Town
Nizampet Road
Kukatpally
Hyderabad Telangana 500072 / IN
03 / BATTHINI, Guruswamy
Flat No. 403 Sri Saichandra Residence
Madhavi Nagar
Bhagya Nagar Colony
Kukatpally
Hyderabad Telangana 500074 / IN
04 / GURRAM, Venkata Narayana
SVS Vaibhay Apartments
Flat No. 204 Pragatools Colony
Pipeline Road
Jeedimetla Village
Hyderabad Telangana 500055 / IN
05 / DONGARI, Naresh
Kalakova (Village&Post)
Munagala (Mandal)
Nalgonda (Dist.)
Telangana 508213 / IN
 [2018/12]
Representative(s)Dall'Olio, Christian, et al
INVENTION S.r.l. Via delle Armi, 1
40137 Bologna / IT
[2018/12]
Application number, filing date15891747.614.12.2015
[2018/12]
WO2015IN00460
Priority number, dateIN2015CHE233908.05.2015         Original published format: IN 2339CH2015
[2018/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016181406
Date:17.11.2016
Language:EN
[2016/46]
Type: A1 Application with search report 
No.:EP3294724
Date:21.03.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 17.11.2016 takes the place of the publication of the European patent application.
[2018/12]
Search report(s)International search report - published on:IN17.11.2016
(Supplementary) European search report - dispatched on:EP24.10.2018
ClassificationIPC:C07D401/12, C07D215/227, C07D215/22
[2018/12]
CPC:
C07D215/227 (EP,US); C07D215/22 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/12]
TitleGerman:VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON ARIPIPRAZOL MIT VERRINGERTER PARTIKELGRÖSSE[2018/12]
English:IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE WITH REDUCED PARTICLE SIZE[2018/12]
French:PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION D'ARIPIPRAZOLE DOTÉ D'UNE TAILLE DE PARTICULE RÉDUITE[2018/12]
Entry into regional phase06.12.2017National basic fee paid 
06.12.2017Search fee paid 
06.12.2017Designation fee(s) paid 
06.12.2017Examination fee paid 
Examination procedure14.09.2016Request for preliminary examination filed
International Preliminary Examining Authority: IN
06.12.2017Examination requested  [2018/12]
06.12.2017Date on which the examining division has become responsible
21.05.2019Application deemed to be withdrawn, date of legal effect  [2019/47]
26.06.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/47]
Fees paidRenewal fee
06.12.2017Renewal fee patent year 03
14.12.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2004099152  (DELMAR CHEMICALS INC [CA], et al) [X] 1-3,10 * page 4, Scheme (III); page 7, lines 16-21; pages 9-10, Example 3; claims *;
 [Y]US2007149782  (BRAND MICHAEL [IL], et al) [Y] 4-9 * Example 2; Examples 3 to 8 and the related Table 3; Examples 9-12 and the related Table 4; Reference Example 13; claims *;
 [Y]WO2013020672  (PHARMATHEN SA [GR], et al) [Y] 4-9 * page 3, line 24-38; page 5, lines 9-21; page 6, Example 3; claims, e.g. Claims 11, 12 *
International search[Y]US2004192915  (TSUJIMORI HISAYUKI [JP], et al) [Y] 1-10 * . Abstract, page no.1-3 para no.[0024, 0028,0030,0031,0039], example-1, claim-1-9 *;
 [X]US2006079689  (NADDAKA VLADIMIR [IL], et al) [X] 4-9 * Abstract, page no. 3-5, Scheme-3,4, Example-2, 3, 10, 13, claims-1-4, 13, 22-27, 32-38 *;
 [X]WO2005077904  (TEVA PHARMA [IL], et al) [X] 4-9 * Abstract, page no. 1-5, Example-3, claims-1-3, 7-10, 16 *;
 [Y]US2006258869  (DESHPANDE PANDURANG B [IN], et al) [Y] 1-10 * Abstract, page no.1-6, claims 4-8,10,12 *;
 [X]WO2013020672  (PHARMATHEN SA [GR], et al) [X] 4-9 * . Page no.2-4, Step a-b at page no. 4, Example-1-2, claims 1-6 *;
 [X]US2007149782  (BRAND MICHAEL [IL], et al) [X] 4-9 * . Page no.2-5, , Example-13, claims 1,6-12,14-15 *;
 [Y]WO2007118923  (FERMION OY [FI], et al) [Y] 1-10 * . Page no. 2-3, Example-4, claims 1,4-6 *;
 [Y]US2005272742  (WORTHEN DAVID R [US], et al) [Y] 1-10 * . Page no. 4-7 para no. [0042-0048], claims 6-8, 26 *
 [Y]  - YASUO OSHIRO et al., "Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1 H )-quinolinone Derivatives", Journal of Medicinal Chemistry, (19980131), vol. 41, no. 5, pages 658 - 667, XP002520984 [Y] 1-10 * Abstract *

DOI:   http://dx.doi.org/10.1021/jm940608g
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.